Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. (Q48525205)
Jump to navigation
Jump to search
scientific article published on 23 May 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. |
scientific article published on 23 May 2006 |
Statements
Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome (English)
Sunday O Akintoye
Marilyn H Kelly
Beth Brillante
Natasha Cherman
Sarah Turner
Michael T Collins